相关实验视频
Updated: Jan 10, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
与抑郁症患者抗抑郁药诱导的躁狂相关的遗传和临床特征
Shiau-Shian Huang1, Ying-Ting Chao2, Yu-Ning Chen3
1Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei City 11217, Taiwan; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, No. 155, Sec. 2, Li-Nong Street, Beitou District, Taipei 112304, Taiwan; School of Public Health and Graduate Institute of Public Health, College of Public Health, National Defense Medical University, Taipei, Taiwan, No. 161, Section 6, Minquan East Road, Neihu District, Taipei City 114, Taiwan; Nankung psychiatric Hospital, Keelung, Taiwan, No. 91, Jijin 1st Rd., Anle Dist., Keelung City 204018, Taiwan.
抗抑郁剂诱导的躁狂 (AIM) 影响了19.65%的抑郁症患者. 女性性别和精神病相关疾病是关键的临床因素,可能与双相情感障碍有遗传联系.
科学领域:
- 精神病学是一个精神病学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗抑郁药引起的躁狂 (AIM) 是一个令人担忧的问题,特别是在双相情感障碍中.
- 在单极抑郁症中对AIM的研究是有限的,报告的发病率为3.0-8.2%.
研究的目的:
- 在单极抑郁症患者中调查AIM的发病率和临床特征.
- 使用全基因组关联研究 (GWAS) 确定与AIM相关的潜在遗传因素.
主要方法:
- 利用台湾国家健康保险研究数据库和台湾生物银行 (2001-2017).
- 分析了772名抑郁症患者的基因型数据,执行GWAS,单标记关联分析和多基因风险评分计算.
- 使用了PLINK软件进行遗传分析.
主要成果:
- 在服用抗抑郁药或停止服用28天内,AIM发生在19.65%的患者中.
- 重要的临床因素包括女性性别,产后抑郁症,强迫症,严重抑郁症,物质使用障碍和精神病.
- 确定了8种可能与AIM相关的单核酸多态 (SNPs),并发现双极性障碍的高多基因风险得分与AIM风险增加相关.
结论:
- AIM发生在大约五分之一的汉族中国抑郁症患者中,女性性别和并发症是显著的临床预测因素.
- 在GWAS中确定了AIM的潜在遗传标记.
- 对双相情感障碍的遗传倾向可能会增加AIM的可能性,尽管在统计学上并不显著;为了进一步调查,需要更大的样本大小.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
相关概念视频
Mania and Antimanic Drugs: Overview
Bipolar Disorder
Antidepressant Drugs: MAOIs and Other Agents
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Antidepressant Drugs: Overview
Depression: Overview